Sign In

Dr. Kaique Filardi

Dr. Kaique Filardi is a board-certified general surgeon and gastrointestinal (GI) surgeon from the University of São Paulo. He is currently an oncologic surgery research fellow at Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School, and serves as a teaching assistant in the Principles and Practice of Clinical Research (PPCR) program at Harvard Medical School.

Next-Generation FRα-Directed Agents in Ovarian Cancer: What Sofetabart Mipitecan (LY4170156) Developments Mean For Practice

Next-Generation FRα-Directed Agents in Ovarian Cancer: What Sofetabart Mipitecan (LY4170156) Developments Mean For Practice

By Dr. Kaique Filardi

The evERA Trial: A Promising Update For Patients With Metastatic ER+, HER2- Breast Cancer

The evERA Trial: A Promising Update For Patients With Metastatic ER+, HER2- Breast Cancer

By Dr. Kaique Filardi

Giredestrant + Everolimus After CDK4/6 Inhibitors: Clinical Significance of the evERA Phase 3 Trial

Giredestrant + Everolimus After CDK4/6 Inhibitors: Clinical Significance of the evERA Phase 3 Trial

By Dr. Kaique Filardi

LIDERA: The First Oral SERD to Demonstrate a Disease-Free Survival Benefit in Early-Stage HR+ Breast Cancer

LIDERA: The First Oral SERD to Demonstrate a Disease-Free Survival Benefit in Early-Stage HR+ Breast Cancer

By Dr. Kaique Filardi

Why Epkinly Is Suddenly Front and Center in Lymphoma Care — What It Means for Patients?

Why Epkinly Is Suddenly Front and Center in Lymphoma Care — What It Means for Patients?

By Dr. Kaique Filardi

MHQ: Clinical IntelligencePowered by SurvivorNet

Health Panel
Clinical Trials

?

Prefer to talk instead of typing?

Answers offered are informational and do not constitute medical advice. Learn more

Health Profile

Enter health info to personalize results.

What is your gender?

What is your age?

Clinical Trials

Clear List